Sheng Deng

1.4k total citations
50 papers, 865 citations indexed

About

Sheng Deng is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Sheng Deng has authored 50 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Genetics. Recurrent topics in Sheng Deng's work include Drug Transport and Resistance Mechanisms (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Sheng Deng is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Sheng Deng collaborates with scholars based in China, United States and Germany. Sheng Deng's co-authors include Hao Deng, Xia Hong, Wei Zhang, Xiong Deng, Lamei Yuan, Gan Zhou, Yijing He, Linyong Xu, Hong‐Hao Zhou and Rohini Kuner and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Sheng Deng

47 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Deng China 17 279 160 154 118 102 50 865
Yoshikazu Saito Japan 15 355 1.3× 197 1.2× 231 1.5× 96 0.8× 112 1.1× 41 1.0k
Cindy Bandala Mexico 16 243 0.9× 119 0.7× 164 1.1× 75 0.6× 51 0.5× 63 824
Ping Zhu China 19 395 1.4× 113 0.7× 81 0.5× 38 0.3× 44 0.4× 66 904
Zhi Song China 16 322 1.2× 114 0.7× 176 1.1× 51 0.4× 25 0.2× 42 817
Naoki Matsumoto Japan 19 268 1.0× 45 0.3× 162 1.1× 60 0.5× 112 1.1× 70 984
Yu Yang China 17 256 0.9× 147 0.9× 48 0.3× 101 0.9× 26 0.3× 69 997
Di Chen China 19 342 1.2× 75 0.5× 119 0.8× 37 0.3× 31 0.3× 54 969
Ryoichi Nagata Japan 15 239 0.9× 73 0.5× 285 1.9× 57 0.5× 346 3.4× 73 999
Xinsheng Lai China 13 400 1.4× 45 0.3× 94 0.6× 36 0.3× 150 1.5× 37 808
Raquel Guerrero‐Alba Mexico 12 203 0.7× 140 0.9× 190 1.2× 33 0.3× 50 0.5× 29 869

Countries citing papers authored by Sheng Deng

Since Specialization
Citations

This map shows the geographic impact of Sheng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Deng more than expected).

Fields of papers citing papers by Sheng Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Deng. The network helps show where Sheng Deng may publish in the future.

Co-authorship network of co-authors of Sheng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Deng. A scholar is included among the top collaborators of Sheng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Deng. Sheng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yujue, et al.. (2024). YBX1 promotes type H vessel–dependent bone formation in an m5C-dependent manner. JCI Insight. 9(4). 11 indexed citations
3.
Yuan, Lamei, Hanlin Yang, Yadong Guo, et al.. (2023). Analysis ofSOD1variants in Chinese patients with familial amyotrophic lateral sclerosis. QJM. 116(5). 365–374. 5 indexed citations
4.
Yuan, Lamei, Sheng Deng, Xia Hong, et al.. (2023). Identification of novel compound heterozygous variants in the DNAH1 gene of a Chinese family with left-right asymmetry disorder. Frontiers in Molecular Biosciences. 10. 1190162–1190162.
5.
Chen, Jinglan, et al.. (2022). Mortality-Related Risk Factors and Novel Antimicrobial Regimens for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review. Infection and Drug Resistance. Volume 15. 6907–6926. 22 indexed citations
6.
Li, Shao, Yinping Guo, Li Wang, et al.. (2022). Effects of ginsenoside compound K on colitis-associated colorectal cancer and gut microbiota profiles in mice. Annals of Translational Medicine. 10(7). 408–408. 27 indexed citations
7.
Yuan, Lamei, Sheng Deng, Xia Hong, et al.. (2022). Identification of DNAH17 Variants in Han-Chinese Patients With Left–Right Asymmetry Disorders. Frontiers in Genetics. 13. 862292–862292. 6 indexed citations
8.
Hong, Xia, Sheng Deng, Hongbo Xu, et al.. (2021). DNAH11 compound heterozygous variants cause heterotaxy and congenital heart disease. PLoS ONE. 16(6). e0252786–e0252786. 10 indexed citations
9.
Zhou, Jiecan, Fazhong He, Bao Sun, et al.. (2019). Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension. Frontiers in Pharmacology. 10. 236–236. 8 indexed citations
10.
Deng, Sheng, et al.. (2018). Mutation Analysis of the ATP7B Gene in Seven Chinese Families with Wilson’s Disease. Digestion. 99(4). 319–326. 4 indexed citations
11.
Chen, Qian, Lamei Yuan, Xiong Deng, et al.. (2017). A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy. Molecular Neurobiology. 55(6). 4911–4917. 18 indexed citations
12.
Deng, Hao, Sheng Deng, Hongbo Xu, et al.. (2016). Exome Sequencing of a Pedigree Reveals S339L Mutation in the TLN2 Gene as a Cause of Fifth Finger Camptodactyly. PLoS ONE. 11(5). e0155180–e0155180. 8 indexed citations
13.
Guo, Yi, Huarong Yang, Xiong Deng, et al.. (2013). Genetic analysis of the S100B gene in Chinese patients with Parkinson disease. Neuroscience Letters. 555. 134–136. 23 indexed citations
14.
Fan, Lan, Gan Zhou, Dong Guo, et al.. (2011). The Pregnane X Receptor Agonist St Johnʼs Wort Has No Effects on the Pharmacokinetics and Pharmacodynamics of Repaglinide. Clinical Pharmacokinetics. 50(9). 605–611. 14 indexed citations
15.
Deng, Sheng, Yanchun He, Tao Yin, Li-Ping Long, & Wei Zhang. (2009). [Analysis of adverse drug reaction of gatifloxacin in Hunan province from Aug. 2003 to Jul. 2007].. PubMed. 34(1). 49–53. 1 indexed citations
17.
Zhang, Wei, Sheng Deng, Xiaoping Chen, et al.. (2008). Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study. Clinical Therapeutics. 30(7). 1283–1289. 31 indexed citations
18.
Zhang, Wei, Bi‐Lian Chen, Vural Özdemir, et al.. (2007). SLCO1B1 521T→C functional genetic polymorphism and lipid‐lowering efficacy of multiple‐dose pravastatin in Chinese coronary heart disease patients. British Journal of Clinical Pharmacology. 64(3). 346–352. 58 indexed citations
19.
Zhang, Wei, Yijing He, Gan Zhou, et al.. (2007). OATP1B1 POLYMORPHISM IS A MAJOR DETERMINANT OF SERUM BILIRUBIN LEVEL BUT NOT ASSOCIATED WITH RIFAMPICIN‐MEDIATED BILIRUBIN ELEVATION. Clinical and Experimental Pharmacology and Physiology. 34(12). 1240–1244. 64 indexed citations
20.
Deng, Pan-Yue, Li Dai, Dan Luo, et al.. (2006). Involvement of endothelial cell-derived CGRP in heat stress-induced protection of endothelial function. Vascular Pharmacology. 46(4). 238–246. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026